New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...

Both radiotherapy and endocrine therapy are good single-modality options for women 70 years or older with early, favorable ...

Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by ...

Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling ...

Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...

In this deep dive BioSpace explores the opportunities and challenges presented by the FDA’s accelerated approval program.

Cases of the Omicron subvariants have skyrocketed in Western Australia in recent weeks with an average 75 infected patients ...

As of the latest trading close, PFE, a Healthcare sector stock, is trading -18.90% below its 52-week high but remains 4.49% above its 52-week low. The Average True Range (ATR) (14 days) of 0.55 ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients ...

Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster ...

CHARLESTON, W.Va. — West Virginia Attorney General Patrick Morrisey on Thursday said the Circuit Court of Mason County has approved a settlement between the state and pharmaceutical companies Pfizer ...

As a new legislative session is set to start in January, Gov. Kathy Hochul is focused on proposals to alleviate costs for ...